Emphysematous pyelonephritis caused by Raoultella ornithinolytica: a case report.
Raoultella ornithinolytica
Case report
Diabetes
Emphysematous pyelonephritis
Infection
Journal
BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793
Informations de publication
Date de publication:
27 Oct 2024
27 Oct 2024
Historique:
received:
18
01
2024
accepted:
04
10
2024
medline:
28
10
2024
pubmed:
28
10
2024
entrez:
28
10
2024
Statut:
epublish
Résumé
Emphysematous pyelonephritis is a rare and severe urinary tract infection that is potentially life-threatening and easily progresses to septic shock. In this report, we present a unique case of emphysematous pyelonephritis caused by Raoultella ornithinolytica. An 86-year-old man presented with severe back pain of 3 days' duration. He had a history of hypertension and diabetes for more than 20 years, and his infection indicators and serum creatinine were elevated. Abdominal computed tomography revealed an abnormal gas shadow around his right kidney and the anterior edge of his right psoas muscle. Consequently, he was initially diagnosed with emphysematous pyelonephritis. There was no evidence of nephrolithiasis or other anatomical or structural abnormalities that could have precipitated this focal renal infection. Both blood and drainage fluid cultures revealed R. ornithinolytica. After early anti-infection treatment, percutaneous drainage and moderate control of blood glucose, the patient gradually recovered. Emphysematous pyelonephritis caused by R. ornithinolytica is rare but has a high drug resistance rate potentially and may cause severe infections. Early diagnosis, prompt use of antibiotics that are sensitive to the organism, and decompression drainage could be the key to treatment.
Sections du résumé
BACKGROUND
BACKGROUND
Emphysematous pyelonephritis is a rare and severe urinary tract infection that is potentially life-threatening and easily progresses to septic shock. In this report, we present a unique case of emphysematous pyelonephritis caused by Raoultella ornithinolytica.
CASE PRESENTATION
METHODS
An 86-year-old man presented with severe back pain of 3 days' duration. He had a history of hypertension and diabetes for more than 20 years, and his infection indicators and serum creatinine were elevated. Abdominal computed tomography revealed an abnormal gas shadow around his right kidney and the anterior edge of his right psoas muscle. Consequently, he was initially diagnosed with emphysematous pyelonephritis. There was no evidence of nephrolithiasis or other anatomical or structural abnormalities that could have precipitated this focal renal infection. Both blood and drainage fluid cultures revealed R. ornithinolytica. After early anti-infection treatment, percutaneous drainage and moderate control of blood glucose, the patient gradually recovered.
CONCLUSIONS
CONCLUSIONS
Emphysematous pyelonephritis caused by R. ornithinolytica is rare but has a high drug resistance rate potentially and may cause severe infections. Early diagnosis, prompt use of antibiotics that are sensitive to the organism, and decompression drainage could be the key to treatment.
Identifiants
pubmed: 39465368
doi: 10.1186/s12882-024-03791-9
pii: 10.1186/s12882-024-03791-9
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
382Informations de copyright
© 2024. The Author(s).
Références
Schultz EH Jr., Klorfein EH. Emphysematous pyelonephritis. J Urol. 1962;87:762–6.
pubmed: 13909504
doi: 10.1016/S0022-5347(17)65043-2
Girgenti V, Pelizzo G, Amoroso S, Rosone G, Di Mitri M, Milazzo M, et al. Emphysematous pyelonephritis following ureterovesical reimplantation for congenital obstructive megaureter. Front Pead. 2019;7:2. Pediatric Case Report and Review of the Literature.
doi: 10.3389/fped.2019.00002
Shokeir AA, El-Azab M, Mohsen T, El-Diasty T. Emphysematous pyelonephritis: a 15-year experience with 20 cases. Urology. 1997;49(3):343–6.
pubmed: 9123695
doi: 10.1016/S0090-4295(96)00501-8
Sokhal AK, Kumar M, Purkait B, Jhanwar A, Singh K, Bansal A, et al. Emphysematous pyelonephritis: changing trend of clinical spectrum, pathogenesis, management and outcome. Turkish J Urol. 2017;43(2):202–9.
doi: 10.5152/tud.2016.14227
Yang Z, Li Z. Sepsis caused by emphysematous pyelonephritis: a case report. Front Med. 2022;9:1038455.
doi: 10.3389/fmed.2022.1038455
Dutta P, Bhansali A, Singh SK, Gupta KL, Bhat MH, Masoodi SR, et al. Presentation and outcome of emphysematous renal tract disease in patients with diabetes mellitus. Urol Int. 2007;78(1):13–22.
pubmed: 17192727
doi: 10.1159/000096929
Kangjam SM, Irom KS, Khumallambam IS, Sinam RS. Role of Conservative Management in Emphysematous Pyelonephritis - A Retrospective Study. J Clin Diagn Research: JCDR. 2015;9(11):Pc09–11.
Pontin AR, Barnes RD, Joffe J, Kahn D. Emphysematous pyelonephritis in diabetic patients. Br J Urol. 1995;75(1):71–4.
pubmed: 7850302
doi: 10.1111/j.1464-410X.1995.tb07237.x
Somani BK, Nabi G, Thorpe P, Hussey J, Cook J, N’Dow J. Is percutaneous drainage the new gold standard in the management of emphysematous pyelonephritis? Evidence from a systematic review. J Urol. 2008;179(5):1844–9.
pubmed: 18353396
doi: 10.1016/j.juro.2008.01.019
Wan YL, Lo SK, Bullard MJ, Chang PL, Lee TY. Predictors of outcome in emphysematous pyelonephritis. J Urol. 1998;159(2):369–73.
pubmed: 9649241
doi: 10.1016/S0022-5347(01)63919-3
Lu YC, Hong JH, Chiang BJ, Pong YH, Hsueh PR, Huang CY, et al. Recommended initial antimicrobial therapy for Emphysematous Pyelonephritis: 51 cases and 14-Year-experience of a Tertiary Referral Center. Medicine. 2016;95(21):e3573.
pubmed: 27227920
pmcid: 4902344
doi: 10.1097/MD.0000000000003573
Narlawar RS, Raut AA, Nagar A, Hira P, Hanchate V, Asrani A. Imaging features and guided drainage in emphysematous pyelonephritis: a study of 11 cases. Clin Radiol. 2004;59(2):192–7.
pubmed: 14746791
doi: 10.1016/S0009-9260(03)00295-2
Olvera-Posada D, Armengod-Fischer G, Vázquez-Lavista LG, Maldonado-Ávila M, Rosas-Nava E, Manzanilla-García H, et al. Emphysematous pyelonephritis: multicenter clinical and therapeutic experience in Mexico. Urology. 2014;83(6):1280–4.
pubmed: 24726310
doi: 10.1016/j.urology.2014.02.010
Krishnamoorthy S, Zumla A, Sekar H, Muneer A, Thiruvengadam G, Kumaresan N. Prognostic scoring system and risk stratification in patients with emphysematous pyelonephritis: an 11-year prospective study at a tertiary referral centre. BJU Int. 2021;127(4):418–27.
pubmed: 32871043
doi: 10.1111/bju.15225
Zabbo A, Montie JE, Popowniak KL, Weinstein AJ. Bilateral emphysematous pyelonephritis. Urology. 1985;25(3):293–6.
pubmed: 3976120
doi: 10.1016/0090-4295(85)90332-2
Bibi M, Chaker K, Ouanes Y, Baccouch R, Madani MA, Mediouni H et al. Comparison of prognosis of five scoring systems in emphysematous pyelonephritis patients requiring intensive care. International urology and nephrology. 2023.
Costas S. Renal and perirenal emphysema. Br J Urol. 1972;44(3):311–9.
pubmed: 5039763
doi: 10.1111/j.1464-410X.1972.tb10082.x
Flores G, Nellen H, Magaña F, Calleja J. Acute bilateral emphysematous pyelonephritis successfully managed by medical therapy alone: a case report and review of the literature. BMC Nephrol. 2002;3:4.
pubmed: 12057010
pmcid: 116587
doi: 10.1186/1471-2369-3-4
Misgar RA, Mubarik I, Wani AI, Bashir MI, Ramzan M, Laway BA. Emphysematous pyelonephritis: a 10-year experience with 26 cases. Indian J Endocrinol Metabol. 2016;20(4):475–80.
doi: 10.4103/2230-8210.183475
Ubee SS, McGlynn L, Fordham M. Emphysematous pyelonephritis. BJU Int. 2011;107(9):1474–8.
pubmed: 20840327
doi: 10.1111/j.1464-410X.2010.09660.x
Chen KW, Huang JJ, Wu MH, Lin XZ, Chen CY, Ruaan MK. Gas in hepatic veins: a rare and critical presentation of emphysematous pyelonephritis. J Urol. 1994;151(1):125–6.
pubmed: 8254788
doi: 10.1016/S0022-5347(17)34889-9
Arsene C, Saste A, Arul S, Mestrovich J, Kammo R, Elbashir M, et al. A case series of emphysematous pyelonephritis. Case Rep Med. 2014;2014:587926.
pubmed: 24812561
pmcid: 4000642
doi: 10.1155/2014/587926
Aboumarzouk OM, Hughes O, Narahari K, Coulthard R, Kynaston H, Chlosta P, et al. Emphysematous pyelonephritis: time for a management plan with an evidence-based approach. Arab J Urol. 2014;12(2):106–15.
pubmed: 26019934
doi: 10.1016/j.aju.2013.09.005
Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26(3–4):259–65.
Lin Q, Geng Z, Zhang Q. Severe emphysematous pyelonephritis due to nosocomial infection. Asian J Surg. 2023;46(8):3180–1.
pubmed: 36898920
doi: 10.1016/j.asjsur.2023.02.108
Rahim MA, Ananna MA, Iqbal S, Uddin KN, Latif ZA. Emphysematous pyelonephritis: experience at a tertiary care hospital in Bangladesh. J Royal Coll Physicians Edinb. 2021;51(1):19–23.
doi: 10.4997/jrcpe.2021.106
Ngo XT, Nguyen TT, Dobbs RW, Thai MS, Vu DH, Dinh LQV, et al. Prevalence and risk factors of Mortality in Emphysematous Pyelonephritis patients: a Meta-analysis. World J Surg. 2022;46(10):2377–88.
pubmed: 35802159
doi: 10.1007/s00268-022-06647-1
Zhao Y, Fesharaki NJ, Liu H, Luo J. Using data-driven sublanguage pattern mining to induce knowledge models: application in medical image reports knowledge representation. BMC Med Inf Decis Mak. 2018;18(1):61.
doi: 10.1186/s12911-018-0645-3
Falagas ME, Alexiou VG, Giannopoulou KP, Siempos II. Risk factors for mortality in patients with emphysematous pyelonephritis: a meta-analysis. J Urol. 2007;178(3 Pt 1):880–5. quiz 1129.
pubmed: 17631348
doi: 10.1016/j.juro.2007.05.017
Andersen JB. [Emphysematous pyelonephritis. A serious complication of diabetes mellitus]. Ugeskr Laeger. 1992;154(20):1419–21.
pubmed: 1631968
Fatima R, Jha R, Muthukrishnan J, Gude D, Nath V, Shekhar S, et al. Emphysematous pyelonephritis: a single center study. Indian J Nephrol. 2013;23(2):119–24.
pubmed: 23716918
pmcid: 3658289
doi: 10.4103/0971-4065.109418
Lu YC, Chiang BJ, Pong YH, Huang KH, Hsueh PR, Huang CY, et al. Predictors of failure of conservative treatment among patients with emphysematous pyelonephritis. BMC Infect Dis. 2014;14:418.
pubmed: 25074590
pmcid: 4124134
doi: 10.1186/1471-2334-14-418
Tsitouridis I, Michaelides M, Sidiropoulos D, Arvanity M. Renal emphysema in diabetic patients: CT evaluation. Diagnostic and interventional radiology (Ankara. Turkey). 2010;16(3):221–6.
Gaud-Luethi E, Scheffler M, Mendes A. Emphysematous cystitis and pyelonephritis leading to a diagnosis of type 2 diabetes in an older patient. Geriatr Gerontol Int. 2022;22(1):81–3.
pubmed: 34743392
doi: 10.1111/ggi.14306
Abusnina W, Shehata M, Nassri S, Zeid F. Emphysematous cystitis. Cleve Clin J Med. 2019;86(1):10–1.
pubmed: 30624190
doi: 10.3949/ccjm.86a.18063
Bonoan JT, Mehra S, Cunha BA. Emphysematous pyelonephritis. Heart lung: J Crit care. 1997;26(6):501–3.
doi: 10.1016/S0147-9563(97)90044-3
Craig WD, Wagner BJ, Travis MD. Pyelonephritis: radiologic-pathologic review. Radiographics: Rev Publication Radiological Soc North Am Inc. 2008;28(1):255–77. quiz 327-8.
doi: 10.1148/rg.281075171
Elawdy MM, Osman Y, Abouelkheir RT, El-Halwagy S, Awad B, El-Mekresh M. Emphysematous pyelonephritis treatment strategies in correlation to the CT classification: have the current experience and prognosis changed? Int Urol Nephrol. 2019;51(10):1709–13.
pubmed: 31309391
doi: 10.1007/s11255-019-02220-3
Wan YL, Lee TY, Bullard MJ, Tsai CC. Acute gas-producing bacterial renal infection: correlation between imaging findings and clinical outcome. Radiology. 1996;198(2):433–8.
pubmed: 8596845
doi: 10.1148/radiology.198.2.8596845
Huang JJ, Tseng CC. Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med. 2000;160(6):797–805.
pubmed: 10737279
doi: 10.1001/archinte.160.6.797
Boakes E, Batura D. Deriving a management algorithm for emphysematous pyelonephritis: can we rely on minimally invasive strategies or should we be opting for earlier nephrectomy? Int Urol Nephrol. 2017;49(12):2127–36.
pubmed: 28933020
doi: 10.1007/s11255-017-1706-8
Kapoor R, Muruganandham K, Gulia AK, Singla M, Agrawal S, Mandhani A, et al. Predictive factors for mortality and need for nephrectomy in patients with emphysematous pyelonephritis. BJU Int. 2010;105(7):986–9.
pubmed: 19930181
doi: 10.1111/j.1464-410X.2009.08930.x
Michaeli J, Mogle P, Perlberg S, Heiman S, Caine M. Emphysematous pyelonephritis. J Urol. 1984;131(2):203–8.
pubmed: 6366247
doi: 10.1016/S0022-5347(17)50309-2
Ahlering TE, Boyd SD, Hamilton CL, Bragin SD, Chandrasoma PT, Lieskovsky G, et al. Emphysematous pyelonephritis: a 5-year experience with 13 patients. J Urol. 1985;134(6):1086–8.
pubmed: 4057396
doi: 10.1016/S0022-5347(17)47635-X
Shah HN. Is there still a role of nephrectomy in management of emphysematous pyelonephritis in today’s era? J Postgrad Med. 2021;67(3):130–1.
pubmed: 34427277
pmcid: 8445115
doi: 10.4103/jpgm.JPGM_337_21
Chen MT, Huang CN, Chou YH, Huang CH, Chiang CP, Liu GC. Percutaneous drainage in the treatment of emphysematous pyelonephritis: 10-year experience. J Urol. 1997;157(5):1569–73.
pubmed: 9112478
doi: 10.1016/S0022-5347(01)64797-9
Arrambide-Herrera JG, Robles-Torres JI, Ocaña-Munguía MA, Romero-Mata R, Gutiérrez-González A, Gómez-Guerra LS. Predictive factors for mortality and intensive care unit admission in patients with emphysematous pyelonephritis: 5-year experience in a tertiary care hospital. Actas Urol Esp. 2022;46(2):98–105.
pubmed: 35120854
doi: 10.1016/j.acuro.2021.01.007
Trujillo-Santamaría H, Robles-Torres JI, Teoh JY, Tanidir Y, Campos-Salcedo JG, Bravo-Castro EI, et al. A novel mortality risk score for emphysematous pyelonephritis: a multicenter study of the Global Research in the Emphysematous Pyelonephritis group. Curr Urol. 2024;18(1):55–60.
pubmed: 38505163
doi: 10.1097/CU9.0000000000000163
Ozawa M, Ichiyanagi O, Fujita S, Naito S, Fukuhara H, Suenaga S, et al. Risk of SOFA deterioration in Conservative Treatment for Emphysematous Pyelonephritis: pitfalls of current trends in therapeutics from Multicenter Clinical Experience. Curr Urol. 2019;12(3):134–41.
pubmed: 31316321
pmcid: 6613313
doi: 10.1159/000489431
Sharma PK, Sharma R, Vijay MK, Tiwari P, Goel A, Kundu AK. Emphysematous pyelonephritis: our experience with conservative management in 14 cases. Urol Annals. 2013;5(3):157–62.
doi: 10.4103/0974-7796.115734
Eswarappa M, Suryadevara S, John MM, Kumar M, Reddy SB, Suhail M. Emphysematous Pyelonephritis Case Series from South India. Kidney Int Rep. 2018;3(4):950–5.
pubmed: 29988992
doi: 10.1016/j.ekir.2017.12.003
Adapala RR, Shetty R, Venugopal P, Prabhu GGL, Yalla D, Unnikrishnan B. Renal salvage, an achievable goal in patients with emphysematous pyelonephritis: outcomes of an algorithmic renal preserving strategy. Urol Annals. 2020;12(2):156–62.
doi: 10.4103/UA.UA_67_19
Ideguchi S, Yamamoto K, Ikeda A, Hashimoto K, Takazono T, Saijo T, et al. A case of bilateral emphysematous pyelonephritis caused by Candida albicans. J Infect Chemotherapy: Official J Japan Soc Chemother. 2019;25(4):302–6.
doi: 10.1016/j.jiac.2018.10.011
Seng P, Boushab BM, Romain F, Gouriet F, Bruder N, Martin C, et al. Emerging role of Raoultella ornithinolytica in human infections: a series of cases and review of the literature. Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis. 2016;45:65–71.
Chun S, Yun JW, Huh HJ, Lee NY. Clinical characteristics of Raoultella ornithinolytica bacteremia. Infection. 2015;43(1):59–64.
pubmed: 25367410
doi: 10.1007/s15010-014-0696-z
Levorova J, Machon V, Guha A, Foltan R. Septic arthritis of the temporomandibular joint caused by rare bacteria Raoultella Ornithinolytica. Int J Oral Maxillofac Surg. 2017;46(1):111–5.
pubmed: 27726907
doi: 10.1016/j.ijom.2016.09.008
Drancourt M, Bollet C, Carta A, Rousselier P. Phylogenetic analyses of Klebsiella species delineate Klebsiella and Raoultella gen. nov., with description of Raoultella ornithinolytica comb. nov., Raoultella terrigena comb. nov. and Raoultella planticola comb. Nov. Int J Syst Evol MicroBiol. 2001;51(Pt 3):925–32.
pubmed: 11411716
doi: 10.1099/00207713-51-3-925
Büyükcam A, Liste Ü, Bıçakçıgil A, Kara A, Sancak B. A case of Raoultella ornithinolytica urinary tract infection in a pediatric patient. J Infect Chemotherapy: Official J Japan Soc Chemother. 2019;25(6):467–9.
doi: 10.1016/j.jiac.2018.12.011
Yamakawa K, Yamagishi Y, Miyata K, Shimomura Y, Iwata A, Hori T, et al. Bacteremia caused by Raoultella ornithinolytica in two children. Pediatr Infect Dis J. 2016;35(4):452–3.
pubmed: 26974750
doi: 10.1097/INF.0000000000001050
Chen X, Zhou X, Cao J, Ma K, Xia Z. A case report of community-acquired Raoultella ornithinolytica infection in a healthy, young individual. BMC Infect Dis. 2021;21(1):1095.
pubmed: 34689741
pmcid: 8542406
doi: 10.1186/s12879-021-06799-w
Sękowska A. Raoultella spp.-clinical significance, infections and susceptibility to antibiotics. Folia Microbiol. 2017;62(3):221–7.
doi: 10.1007/s12223-016-0490-7
Kabbara WK, Zgheib YR. Diabetic foot infection caused by Raoultella ornithinolytica. Am J Health Syst Pharm. 2015;72(24):2147–9.
Morais VP, Daporta MT, Bao AF, Campello MG, Andrés GQ. Enteric fever-like syndrome caused by Raoultella ornithinolytica (Klebsiella ornithinolytica). J Clin Microbiol. 2009;47(3):868–9.
pubmed: 19144809
doi: 10.1128/JCM.01709-08
Alves MS, Dias RC, de Castro AC, Riley LW, Moreira BM. Identification of clinical isolates of indole-positive and indole-negative Klebsiella spp. J Clin Microbiol. 2006;44(10):3640–6.
pubmed: 16928968
pmcid: 1594763
doi: 10.1128/JCM.00940-06
Monnet D, Freney J. Method for differentiating Klebsiella planticola and Klebsiella terrigena from other Klebsiella species. J Clin Microbiol. 1994;32(4):1121–2.
pubmed: 8027329
pmcid: 267203
doi: 10.1128/jcm.32.4.1121-1122.1994
Park JS, Hong KH, Lee HJ, Choi SH, Song SH, Song KH, et al. Evaluation of three phenotypic identification systems for clinical isolates of Raoultella ornithinolytica. J Med Microbiol. 2011;60(Pt 4):492–9.
pubmed: 21212145
doi: 10.1099/jmm.0.020768-0
Kanki M, Yoda T, Tsukamoto T, Shibata T. Klebsiella pneumoniae produces no histamine: Raoultella planticola and Raoultella ornithinolytica strains are histamine producers. Appl Environ Microbiol. 2002;68(7):3462–6.
pubmed: 12089029
pmcid: 126807
doi: 10.1128/AEM.68.7.3462-3466.2002
Sekowska A, Mikucka A, Gospodarek-Komkowska E. Identification of Raoultella spp.: comparison of three methods. Ind J Med Microbiol. 2018;36(2):197–200.
doi: 10.4103/ijmm.IJMM_17_99
Appel TM, Quijano-Martínez N, De La Cadena E, Mojica MF, Villegas MV. Microbiological and clinical aspects of Raoultella spp. Front Public Health. 2021;9:686789.
pubmed: 34409007
pmcid: 8365188
doi: 10.3389/fpubh.2021.686789
Hadano Y, Tsukahara M, Ito K, Suzuki J, Kawamura I, Kurai H. Raoultella ornithinolytica bacteremia in cancer patients: report of three cases. Intern Med (Tokyo Japan). 2012;51(22):3193–5.
doi: 10.2169/internalmedicine.51.8349
Haruki Y, Hagiya H, Sakuma A, Murase T, Sugiyama T, Kondo S. Clinical characteristics of Raoultella ornithinolytica bacteremia: a case series and literature review. J Infect Chemotherapy: Official J Japan Soc Chemother. 2014;20(9):589–91.
doi: 10.1016/j.jiac.2014.05.005
Bhatt P, Tandel K, Das NK, Rathi KR. New Delhi metallo-β-lactamase producing extensively drug-resistant Raoultella ornithinolytica isolated from drain fluid following Whipple’s pancreaticoduodenectomy. Medical journal. Armed Forces India. 2015;71(Suppl 2):S609–11.
doi: 10.1016/j.mjafi.2015.01.005
Hajjar R, Schwenter F, Su SH, Gasse MC, Sebajang H. Community-acquired infection to Raoultella ornithinolytica presenting as appendicitis and shock in a healthy individual. J Surg case Rep. 2018;2018(5):rjy097.
pubmed: 29780575
pmcid: 5952952
doi: 10.1093/jscr/rjy097
Surani A, Slama EM, Thomas S, Ross RW, Cunningham SC. Raoultella ornithinolytica and Klebsiella oxytoca pyogenic liver abscess presenting as chronic cough. IDCases. 2020;20:e00736.
pubmed: 32211296
pmcid: 7082512
doi: 10.1016/j.idcr.2020.e00736
Goggins A, Lykins J, Aston A, Shaw J. Acute cholecystitis secondary to Raoultella ornithinolytica infection, complicated by sepsis, gallbladder perforation, hepatic abscess and bacteraemia. BMJ case Rep. 2022;15(12).
De Petris L, Ruffini E. Roultella Ornithinolytica infection in infancy: a case of febrile urinary tract infection. CEN case Rep. 2018;7(2):234–6.
pubmed: 29721836
pmcid: 6181883
doi: 10.1007/s13730-018-0333-2
Nakasone ES, Kaneshiro R, Min K, Tokeshi J. Emergence of Raoultella ornithinolytica on O’ahu: a case of community-acquired R. ornithinolytica urinary tract infection. Hawai’i J Med Public Health: J Asia Pac Med Public Health. 2015;74(5):174–5.
Romero Pérez P. [Tract infections by the genus Raoultella. Literature review and contribution of 1 case of Raoultella ornithinolytica]. Arch Esp Urol. 2021;74(3):276–86.
pubmed: 33818423
Lam PW, Tadros M, Fong IW. Mandibular osteomyelitis due to Raoultella species. JMM case Rep. 2018;5(3):e005140.
pubmed: 29623214
pmcid: 5884960
doi: 10.1099/jmmcr.0.005140
Zheng B, Zhang J, Ji J, Fang Y, Shen P, Ying C, et al. Emergence of Raoultella ornithinolytica coproducing IMP-4 and KPC-2 carbapenemases in China. Antimicrob Agents Chemother. 2015;59(11):7086–9.
pubmed: 26282422
pmcid: 4604418
doi: 10.1128/AAC.01363-15
Seng P, Theron F, Honnorat E, Prost D, Fournier PE, Stein A. Raoultella ornithinolytica: an unusual pathogen for prosthetic joint infection. IDCases. 2016;5:46–8.
pubmed: 27500082
pmcid: 4969086
doi: 10.1016/j.idcr.2016.07.003
Venus K, Vaithilingam S, Bogoch II. Septic arthritis of the knee due to Raoultella ornithinolytica. Infection. 2016;44(5):691–2.
pubmed: 27488819
doi: 10.1007/s15010-016-0930-y
Schmutz N, Adler T, Schelhorn N, Wirz S, Fricker R. [Postoperative osteomyelitis of a distal phalanx caused by Raoultella ornithinolytica]. Handchirurgie, Mikrochirurgie, plastische chirurgie: Organ Der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ Der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie Der. Peripheren Nerven Und Gefasse. 2016;48(3):175–8.
Graham GD, Jeray KJ. Posttraumatic patellar osteomyelitis due to Raoultella ornithinolytica: a Case Report. JBJS case Connect. 2023;13(1).
Solak Y, Gul EE, Atalay H, Genc N, Tonbul HZ. A rare human infection of Raoultella ornithinolytica in a diabetic foot lesion. Ann Saudi Med. 2011;31(1):93–4.
pubmed: 21245606
pmcid: 3101735
doi: 10.4103/0256-4947.75794
Khajuria A, Praharaj AK, Grover N, Kumar M. First report of blaNDM-1 in Raoultella ornithinolytica. Antimicrob Agents Chemother. 2013;57(2):1092–3.
pubmed: 23165470
pmcid: 3553683
doi: 10.1128/AAC.02147-12
Ayoade F, Mada PK, Alam M. Fat necrosis and polymicrobial wound infection caused partly by Raoultella ornithinolytica after reduction mammoplasty. BMJ case reports. 2018;2018.
Van Cleve JR, Boucher BA, Smith DV, Croce MA. Ventilator associated pneumonia caused by Raoultella ornithinolytica in two immunocompetent trauma patients. Respiratory Med case Rep. 2018;24:135–7.
Jellinge ME. Raoultella Ornithinolytica Diagnosed in a Neurointensive patient. A rare case with recovery without antibiotics. J Crit Care Med (Targu Mures). 2017;3(3):120–2.
Papakanderaki E, Kanakakis K, Goule S, Chounti M, Hountis P. Clinical significance of positive Raoultella Ornithinolytica and Staphylococcus hominis cultures in a post lobectomy patient. A case report. Monaldi Archives Chest Disease = Archivio Monaldi per le malattie del torace. 2018;88(1):885.
Hinchcliffe N, Benbow A, Moshiri T, Thompson J, Venkatesan P. Isolation of Raoultella ornithinolytica in a HIV positive patient with a lung abscess. Access Microbiol. 2022;4(6):acmi000365.
pubmed: 36004361
pmcid: 9394669
doi: 10.1099/acmi.0.000365
Hajjar R, Ambaraghassi G, Sebajang H, Schwenter F, Su SH. Raoultella ornithinolytica: emergence and resistance. Infect drug Resist. 2020;13:1091–104.
pubmed: 32346300
pmcid: 7167274
doi: 10.2147/IDR.S191387
Castanheira M, Deshpande LM, DiPersio JR, Kang J, Weinstein MP, Jones RN. First descriptions of blaKPC in Raoultella spp. (R. Planticola and R. Ornithinolytica): report from the SENTRY Antimicrobial Surveillance Program. J Clin Microbiol. 2009;47(12):4129–30.
pubmed: 19812278
pmcid: 2786659
doi: 10.1128/JCM.01502-09
Kaya S, Bayramoğlu G, Sönmez M, Köksal İ. Raoultella ornithinolytica causing fatal sepsis. Brazilian J Infect Diseases: Official Publication Brazilian Soc Infect Dis. 2015;19(2):230–1.
doi: 10.1016/j.bjid.2014.12.010
Abbas A, Ahmad I. First report of neonatal early-onset sepsis caused by multi-drug-resistant Raoultella ornithinolytica. Infection. 2018;46(2):275–7.
pubmed: 29103080
doi: 10.1007/s15010-017-1098-9
González-Castro A, Rodríguez-Borregán JC, Campos S, Pérez Canga JL. Catheter-related bacteraemia caused by Raoultella ornithinolytica. Rev Esp Anestesiol Reanim. 2018;65(2):116–8.
doi: 10.1016/j.redar.2017.09.007
Zou H, Berglund B, Wang S, Zhou Z, Gu C, Zhao L et al. Emergence of bla(NDM-1), bla(NDM-5), bla(KPC-2) and bla(IMP-4) carrying plasmids in Raoultella spp. in the environment. Environmental pollution (Barking, Essex: 1987). 2022;306:119437.
Zou H, Berglund B, Xu H, Chi X, Zhao Q, Zhou Z et al. Genetic characterization and virulence of a carbapenem-resistant Raoultella ornithinolytica isolated from well water carrying a novel megaplasmid containing bla(NDM-1). Environmental pollution (Barking, Essex: 1987). 2020;260:114041.
Dang B, Zhang H, Li Z, Ma S, Xu Z. Coexistence of the bla(NDM-1)-carrying plasmid pWLK-NDM and the bla(KPC-2)-carrying plasmid pWLK-KPC in a Raoultella ornithinolytica isolate. Sci Rep. 2020;10(1):2360.
pubmed: 32047243
pmcid: 7012882
doi: 10.1038/s41598-020-59341-4
Pas ML, Vanneste K, Bokma J, Van Driessche L, De Keersmaecker SCJ, Roosens NH, et al. Case Report: Multidrug Resistant Raoultella ornithinolytica in a septicemic calf. Front Veterinary Sci. 2021;8:631716.
doi: 10.3389/fvets.2021.631716
Cortés-Ortíz IA, Mendieta-Condado E, Escobar-Escamilla N, Juárez-Gómez JC, Garcés-Ayala F, Rodriguez AA, et al. Multidrug-resistant Raoultella ornithinolytica misidentified as Klebsiella oxytoca carrying blaOXA β-lactamases: antimicrobial profile and genomic characterization. Arch Microbiol. 2021;203(9):5755–61.
pubmed: 34499216
doi: 10.1007/s00203-021-02515-z
Villacís JE, Castelán-Sánchez HG, Rojas-Vargas J, Rodríguez-Cruz UE, Albán V, Reyes JA, et al. Emergence of Raoultella ornithinolytica in human infections from different hospitals in Ecuador with OXA-48-producing resistance. Front Microbiol. 2023;14:1216008.
pubmed: 37692398
pmcid: 10484340
doi: 10.3389/fmicb.2023.1216008
Tayo A, Nyame K. Sepsis from multisystem infection with Multidrug-Resistant Raoultella ornithinolytica. Cureus. 2022;14(1):e20975.
pubmed: 35154953
pmcid: 8816680
Baek J, Park MJ, Lee HY, Kang S. Raoultella Ornithinolytica in a healthy, young person: rapidly progressive sinusitis with Orbital and Intracranial involvement. Eur J case Rep Intern Med. 2023;10(10):003987.
pubmed: 37789980
pmcid: 10545151
Gajdács M, Ábrók M, Lázár A, Burián K. Comparative epidemiology and Resistance trends of common urinary pathogens in a tertiary-care hospital: a 10-Year Surveillance Study. Med (Kaunas Lithuania). 2019;55(7).
Pacilli M, Nataraja RM. Raoultella planticola associated with Meckel’s diverticulum perforation and peritonitis in a child: case report and systematic review of the paediatric literature. J Infect Public Health. 2019;12(5):605–7.
pubmed: 31104988
doi: 10.1016/j.jiph.2019.05.003
Stock I, Wiedemann B. Natural antibiotic susceptibility of Klebsiella pneumoniae, K. Oxytoca, K. Planticola, K. Ornithinolytica and K. terrigena strains. J Med Microbiol. 2001;50(5):396–406.
pubmed: 11339246
doi: 10.1099/0022-1317-50-5-396
Walckenaer E, Poirel L, Leflon-Guibout V, Nordmann P, Nicolas-Chanoine MH. Genetic and biochemical characterization of the chromosomal class a beta-lactamases of Raoultella (formerly Klebsiella) planticola and Raoultella ornithinolytica. Antimicrob Agents Chemother. 2004;48(1):305–12.
pubmed: 14693555
pmcid: 310189
doi: 10.1128/AAC.48.1.305-312.2004
Wu SY, Yang SS, Chang SJ, Hsu CK. Emphysematous pyelonephritis: classification, management, and prognosis. Tzu Chi Med J. 2022;34(3):297–302.
pubmed: 35912050
pmcid: 9333110
doi: 10.4103/tcmj.tcmj_257_21